<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">gnck</journal-id><journal-title-group><journal-title xml:lang="ru">Колопроктология</journal-title><trans-title-group xml:lang="en"><trans-title>Koloproktologia</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2073-7556</issn><issn pub-type="epub">2686-7303</issn><publisher><publisher-name>Russian Association of Coloproctology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.33878/2073-7556-2023-22-3-76-84</article-id><article-id custom-type="elpub" pub-id-type="custom">gnck-1828</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Валидация опросника по оценке степени риска обнаружения колоректального рака</article-title><trans-title-group xml:lang="en"><trans-title>Validation of the risk questionnaire for colorectal cancer detection</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1641-6751</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Куловская</surname><given-names>Д. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Kulovskaya</surname><given-names>D. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ул. Саляма Адиля, д. 2, г. Москва, 123423</p><p>ул. Баррикадная, д. 2/1, г. Москва, 125993</p></bio><bio xml:lang="en"><p>Salyama Adilya st., 2, Moscow, 123423</p></bio><email xlink:type="simple">d.p.barmina@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8480-9362</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шелыгин</surname><given-names>Ю. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Shelygin</surname><given-names>Yu. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ул. Саляма Адиля, д. 2, г. Москва, 123423</p><p>ул. Баррикадная, д. 2/1, г. Москва, 125993</p></bio><bio xml:lang="en"><p>Salyama Adilya st., 2, Moscow, 123423</p><p>Barrikadnaya st., 2/1, Moscow, 125993</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4697-2839</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Фролов</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Frolov</surname><given-names>S. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ул. Саляма Адиля, д. 2, г. Москва, 123423</p></bio><bio xml:lang="en"><p>Salyama Adilya st., 2, Moscow, 123423</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9294-5447</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ачкасов</surname><given-names>С. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Achkasov</surname><given-names>S. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ул. Саляма Адиля, д. 2, г. Москва, 123423</p><p>ул. Баррикадная, д. 2/1, г. Москва, 125993</p></bio><bio xml:lang="en"><p>Salyama Adilya st., 2, Moscow, 123423</p><p>Barrikadnaya st., 2/1, Moscow, 125993</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ "НМИЦ колопроктологии имени А.Н.Рыжих" Минздрава России; ФГБОУ РМАНПО Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Ryzhih National Medical Research Center of Coloproctology</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУ "НМИЦ колопроктологии имени А.Н.Рыжих" Минздрава России; ФГБОУ РМАНПО Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Ryzhih National Medical Research Center of Coloproctology; Russian Medical Academy of Continuous Professional Education</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГБУ "НМИЦ колопроктологии имени А.Н.Рыжих" Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Ryzhih National Medical Research Center of Coloproctology</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>21</day><month>09</month><year>2023</year></pub-date><volume>22</volume><issue>3</issue><fpage>76</fpage><lpage>84</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Куловская Д.П., Шелыгин Ю.А., Фролов С.А., Ачкасов С.И., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Куловская Д.П., Шелыгин Ю.А., Фролов С.А., Ачкасов С.И.</copyright-holder><copyright-holder xml:lang="en">Kulovskaya D.P., Shelygin Y.A., Frolov S.A., Achkasov S.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.ruproctology.com/jour/article/view/1828">https://www.ruproctology.com/jour/article/view/1828</self-uri><abstract><sec><title>ЦЕЛЬ</title><p>ЦЕЛЬ: провести валидацию опросника (анкеты) по выявлению степени вероятности обнаружения колоректального рака.</p></sec><sec><title>ПАЦИЕНТЫ И МЕТОДЫ</title><p>ПАЦИЕНТЫ И МЕТОДЫ: в проспективное продольное исследование включены 697 пациентов, впервые обратившихся к врачу-колопроктологу, которым было проведено анкетирование и колоноскопия. Для оценки значимости риска развития КРР каждого отдельного вопроса в анкете для определения риска выявления колоректального рака (КРР), было проведено статистическое моделирование при помощи регрессионного анализа.</p></sec><sec><title>РЕЗУЛЬТАТЫ</title><p>РЕЗУЛЬТАТЫ: выявлено, что КРР был диагностирован у 39 (5,6%) пациентов, доброкачественные образования толстой кишки у 283 (40,6%) пациентов. Установлено, что вопросы, включенные в анкету, имеют различную значимость для определения степени риска обнаружения колоректального рака и доброкачественных образований толстой кишки, а определенное сочетание данных вопросов является прогностическим фактором их выявления. При ROC-анализе установлена точка отсечки в 23 балла, которая делит группу больных на респондентов с высоким и низким риском наличия новообразований толстой кишки с чувствительностью 92,8% и специфичностью 39,2%. Площадь под кривой составила 0,724, что соответствует хорошей прогностической значимости модели.</p></sec><sec><title>ЗАКЛЮЧЕНИЕ</title><p>ЗАКЛЮЧЕНИЕ: разработанный опросник позволяет определять степень риска обнаружения колоректального рака и может быть включен в модель скрининговой программы.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>AIM</title><p>AIM: to develop and validate of the colorectal cancer screening questionnaire.</p></sec><sec><title>PATIENTS AND METHODS</title><p>PATIENTS AND METHODS: six hundred ninety seven patients without any significant complaints were prospectively included in study. All patients underwent colonoscopy and specific questionnaire. Regression model was performed to stratificate significance level of definite questions.</p></sec><sec><title>RESULTS</title><p>RESULTS: colorectal cancer (CRC) was diagnosed in 39 (5.6%) patients, benign colon neoplasms — in 283 (40.6%) patients. In the ROC analysis, a cut-off of 23 points divides the group of patients into high and low risk of colorectal neoplasms with a sensitivity of 92.8% and a specificity of 39.2%. The area under the curve was 0.724, which corresponds to the good predictive value.</p></sec><sec><title>CONCLUSION</title><p>CONCLUSION: the developed questionnaire show good predictive power for high CRC risk patients identification, and can be included in the screening program model.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>скрининг колоректального рака</kwd><kwd>колоректальный рак</kwd><kwd>опросник</kwd><kwd>анкетирование</kwd></kwd-group><kwd-group xml:lang="en"><kwd>colorectal cancer screening</kwd><kwd>colorectal cancer</kwd><kwd>questionnaire</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Canc J Clin. 2021; 71(3): 209-249. DOI: 10.3322/caac.21660.</mixed-citation><mixed-citation xml:lang="en">Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Canc J Clin. 2021; 71(3): 209-249. DOI: 10.3322/caac.21660.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Feng Y, Jin H, Guo K, et al. Causes of Death After Colorectal Cancer Diagnosis: A Population-Based Study. Front Oncol. 2021; Mar 30:11:647179. DOI: 10.3389/fonc.2021.647179.</mixed-citation><mixed-citation xml:lang="en">Feng Y, Jin H, Guo K, et al. Causes of Death After Colorectal Cancer Diagnosis: A Population-Based Study. Front Oncol. 2021; Mar 30:11:647179. DOI: 10.3389/fonc.2021.647179.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Каприн А.Д., Старинский В.В, Шахзадов А.О. Состояние онкологической помощи населению в России в 2021 году. М.: МНИОИ им. П. А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2022, 239 с.</mixed-citation><mixed-citation xml:lang="en">Kaprin A.D., Starinsky V.V., Shakhzadova O.A. The state of oncological care for the population of Russia in 2021. Moscow: P.A. Herzen Moscow State Medical Research Institute branch of the Federal State Budgetary Institution “NMIRC” of the Ministry of Health of Russia; 2022, 239 р. (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Каприн А.Д., Старинский В.В, Шахзадов А.О. Злокачественные новообразования в России в 2021 году (заболеваемость и смертность). М.: МНИОИ им. П. А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2022, 252 с.</mixed-citation><mixed-citation xml:lang="en">Kaprin A.D., Starinsky V.V., Shakhzadova O.A. Malignant neoplasms in Russiain 2021 (morbidity and mortality). Moscow: P.A.Herzen Moscow State Medical Research Institute – Branch of the Federal State Budgetary Institution "NMIC of Radiology" of the Ministry of Health of Russia, 2022, 252 p. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Hull MA, Rees CJ, Sharp L, et al. A risk-stratified approach to colorectal cancer prevention and diagnosis. Nat Rev Gastroenterol Hepatol. 2020; 17: 773–780. DOI: 10.1038/s41575-020-00368-3.</mixed-citation><mixed-citation xml:lang="en">Hull MA, Rees CJ, Sharp L, et al. A risk-stratified approach to colorectal cancer prevention and diagnosis. Nat Rev Gastroenterol Hepatol. 2020; 17: 773–780. DOI: 10.1038/s41575-020-00368-3.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Siegel RL, Miller KD, Jemal A. Cancer statistics. CA: a cancer journal for clinicians. 2019;69:7-34.</mixed-citation><mixed-citation xml:lang="en">Siegel RL, Miller KD, Jemal A. Cancer statistics. CA: a cancer journal for clinicians. 2019;69:7-34.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Issa IA, Noureddine M. Colorectal cancer screening: An updated review of the available options. World Journal of Gastroenterology. 2018; 23(28): 5086–5096. DOI:10.3748/wjg.v23.i28.5086.</mixed-citation><mixed-citation xml:lang="en">Issa IA, Noureddine M. Colorectal cancer screening: An updated review of the available options. World Journal of Gastroenterology. 2018; 23(28): 5086–5096. DOI:10.3748/wjg.v23.i28.5086</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Rex DK, Boland R, Dominitz JA, et al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. multi-society task force on colorectal cancer. Am J Gastroenterol. 2017;30: 112:1016.DOI: 10.1038/ajg.2017.174.</mixed-citation><mixed-citation xml:lang="en">Rex DK, Boland R, Dominitz JA, et al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. multi-society task force on colorectal cancer. Am J Gastroenterol. 2017;30: 112:1016.DOI: 10.1038/ajg.2017.174.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Quintero E, Castells A, Bujanda L. Colonoscopy versus Fecal Immunochemical Testing in Colorectal-Cancer Screening. New England Journal of Medicine. 2012; 366(8): 697–706. DOI:10.1056/nejmoa1108895.</mixed-citation><mixed-citation xml:lang="en">Quintero E, Castells A, Bujanda L. Colonoscopy versus Fecal Immunochemical Testing in Colorectal-Cancer Screening. New England Journal of Medicine. 2012; 366(8): 697–706. DOI:10.1056/nejmoa1108895</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Wu W, Huang J, Yang Y, et al. Adherence to colonoscopy in cascade screening of colorectal cancer: A systematic review and meta-analysis. J Gastroenterol Hepatol. 2022; Apr;37(4):620-631. DOI: 10.1111/jgh.15762.</mixed-citation><mixed-citation xml:lang="en">Wu W, Huang J, Yang Y, et al. Adherence to colonoscopy in cascade screening of colorectal cancer: A systematic review and meta-analysis. J Gastroenterol Hepatol. 2022; Apr;37(4):620-631. DOI: 10.1111/jgh.15762</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Bertels L, Lucassen P, van Asselt K, et al. Motives for non-adherence to colonoscopy advice after a positive colorectal cancer screening test result: a qualitative study. Scand J Prim Health Care. 2020 Dec; 38(4):487-498. DOI: 10.1080/02813432.2020.1844391.</mixed-citation><mixed-citation xml:lang="en">Bertels L, Lucassen P, van Asselt K, et al. Motives for non-adherence to colonoscopy advice after a positive colorectal cancer screening test result: a qualitative study. Scand J Prim Health Care. 2020 Dec; 38(4):487-498. DOI: 10.1080/02813432.2020.1844391</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Corley DA, Jensen CD, Marks AR, et al. Adenoma Detection Rate and Risk of Colorectal Cancer and Death. New England Journal of Medicine. 2014; 370(14): 1298–1306. DOI:10.1056/nejmoa1309086.</mixed-citation><mixed-citation xml:lang="en">Corley DA, Jensen CD, Marks AR, et al. Adenoma Detection Rate and Risk of Colorectal Cancer and Death. New England Journal of Medicine. 2014; 370(14): 1298–1306. DOI:10.1056/nejmoa1309086.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Saw KS, Liu C, Xu W, et al. Faecal immunochemical test to triage patients with possible colorectal cancer symptoms: meta-analysis. Br J Surg. 2022 Feb 1;109(2):182-190. DOI: 10.1093/bjs/znab411.</mixed-citation><mixed-citation xml:lang="en">Saw KS, Liu C, Xu W, et al. Faecal immunochemical test to triage patients with possible colorectal cancer symptoms: meta-analysis. Br J Surg. 2022 Feb 1;109(2):182-190. DOI: 10.1093/bjs/znab411</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Benton SC, Piggott C, Blyuss O, et al. Impact of changing from a guaiac faecal occult blood test to a faecal immunochemical test in a national screening programme: Results from a pilot study within the national bowel cancer screening programme in England. J Med Screen. 2021 Dec;28(4):426-432. DOI: 10.1177/09691413211013376.</mixed-citation><mixed-citation xml:lang="en">Benton SC, Piggott C, Blyuss O, et al. Impact of changing from a guaiac faecal occult blood test to a faecal immunochemical test in a national screening programme: Results from a pilot study within the national bowel cancer screening programme in England. J Med Screen. 2021 Dec;28(4):426-432. DOI: 10.1177/09691413211013376.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Ladabaum, Ur, Dominitz JA, Kahi Ch, et al. Strategies for Colorectal Cancer Screening. Gastroenterology. 2020 Jan;158(2):418-432. DOI: 10.1053/j.gastro.2019.06.043</mixed-citation><mixed-citation xml:lang="en">Ladabaum, Ur, Dominitz JA, Kahi Ch, et al. Strategies for Colorectal Cancer Screening. Gastroenterology. 2020 Jan;158(2):418-432. DOI: 10.1053/j.gastro.2019.06.043</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Hoffman RM, Steel S, Yee EF, et al. Colorectal cancer screening adherence is higher with fecal immunochemical tests than guaiac-based fecal occult blood tests: a randomized, controlled trial. Prev Med. 2010 May-Jun;50(5-6):297-9. DOI: 10.1016/j.ypmed.2010.03.010.</mixed-citation><mixed-citation xml:lang="en">Hoffman RM, Steel S, Yee EF, et al. Colorectal cancer screening adherence is higher with fecal immunochemical tests than guaiac-based fecal occult blood tests: a randomized, controlled trial. Prev Med. 2010 May-Jun;50(5-6):297-9. DOI: 10.1016/j.ypmed.2010.03.010</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Куловская Д.П., Ачкасов С.И., Шелыгин Ю.А., и соавт. Сравнительная оценка эффективности анкетирования и теста на скрытую кровь в кале при скрининге колоректального рака. Хирург. 2022; 4. DOI: 10.33920/med-15-2204-04</mixed-citation><mixed-citation xml:lang="en">Kulovskaya D.P., Achkasov S.I., Shelygin Yu.A., et al. Comparative assessment of questionnaire and fecal immunochemical test efficacy in colorectal cancer screening. Surgeon. 2022;4. (in Russ.). DOI:10.33920/med-15-2204-04.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Finlay A; Macrae RMG, Seres D, et al. Colorectal Cancer: Epidemiology, Risk Factors, and Protective Factors. Available online: https://www.uptodate.com/contents/colorectal-cancer-epidemiologyrisk-factors-and-protective-factors (accessed on 24 December 2018).</mixed-citation><mixed-citation xml:lang="en">Finlay A; Macrae RMG, Seres D, et al. Colorectal Cancer: Epidemiology, Risk Factors, and Protective Factors. Available online: https://www.uptodate.com/contents/colorectal-cancer-epidemiologyrisk-factors-and-protective-factors (accessed on 24 December 2018).</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Mauri G, Sartore-Bianchi A, Russo AG, et al. Early-onset colorectal cancer in young individuals. Mol Oncol. 2019;13:109–31. DOI: 10.1002/1878-0261.12417.</mixed-citation><mixed-citation xml:lang="en">Mauri G, Sartore-Bianchi A, Russo AG, et al. Early-onset colorectal cancer in young individuals. Mol Oncol. 2019;13:109–31. DOI: 10.1002/1878-0261.12417</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
